← SynDRA
ALLITINIB
SynDRA canonical compound SYN0028692 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | ERBB2 |
|---|
| Mechanism of action | EGFR inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- EGFR INHIBITOR
- Epidermal growth factor receptor erbB1 inhibitor
- ERBB2 INHIBITOR
- Receptor protein-tyrosine kinase erbB-2 inhibitor
- ERBB4 INHIBITOR
- EGFR MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABL1
- AKT1
- SYK
- SRC
- RPS6KB1
- PRKCB
- PIM2
- PDGFRB
- PDGFRA
- MST1R
- MET
- KIT
- KDR
- JAK2
- IGF1R
- HDAC6
- GSK3B
- FLT1
- FGFR1
- EPHB2
- EPHA2
- CDK2
- AURKA
- TEK
Cross-references
Synonyms
- Als 1306
- Ast-1306
- Ast1306
- ALL-3
- AST-1306
- Allitinib tosylate
- AST 1306
- AST1306
- ALS-1306
- CX0M5RO7CY
- RefChem:110778
- ALS1306
- DTXCID10597875
- AST-6
- C24H18ClFN4O2
- MFCD17169993
- UNII-CX0M5RO7CY
- SCHEMBL233985
- GTPL9912
- orb1308633
- SCHEMBL29354831
- SCHEMBL31732812
- CHEBI:91467
- EX-A047
- GLXC-15035
- XKB38362
- AKOS025149073
- CS-0983
- SB19364
- SDCCGSBI-0654468.P001
- NCGC00346478-02
- NCGC00346478-04
- NCGC00346478-05
- AC-32040
- HY-15375
- TS-07958
- DB-078476
- T14336
- BRD-K26838195-075-04-9
Look up ALLITINIB in the interactive SynDRA portal →